The use of live donors in intestinal transplantation could potentially
both reduce the severity of rejection responses against this highly i
mmunogenic organ by better tissue matching and also reduce cold ischae
mia times. These two advantages over cadaveric grafts could preserve m
ucosal integrity and reduce the risk of systemic sepsis From bacterial
translocation. The disadvantages of live donation are the inherent ri
sk to the donor and the compromise of using a shorter graft. Although
only a handful of such cases have been performed, the success rate has
been high and this is a therapeutic modality which should be explored
further.